Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

BACKGROUND: The role of dysglycemia as an additional risk factor for atrial fibrillation (AF) is controversial. Therefore, it was of interest to assess risk factors for incident AF in a large, representative population of patients with cardiovascular risk factors and impaired glucose tolerance but...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Latini, R, Staszewsky, L, Sun, J, Bethel, M, Disertori, M, Haffner, S, Holman, R, Chang, F, Giles, T, Maggioni, A, Rutten, G, Standl, E, Thomas, L, Tognoni, G, Califf, R, McMurray, J
Materialtyp:	Journal article
Språk:	English
Publicerad:	2013

Liknande verk

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
av: Preiss, D, et al.
Publicerad: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
av: Califf, R, et al.
Publicerad: (2008)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
av: Preiss, D, et al.
Publicerad: (2012)

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
av: Mcmurray, J, et al.
Publicerad: (2011)

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
av: Krum, H, et al.
Publicerad: (2010)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
av: Currie, G, et al.
Publicerad: (2017)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
av: Sharma, A, et al.
Publicerad: (2016)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
av: Bethel, M, et al.
Publicerad: (2013)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
av: Bethel, M, et al.
Publicerad: (2013)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
av: Yates, T, et al.
Publicerad: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
av: Yates, T, et al.
Publicerad: (2014)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
av: Anke Tönjes, et al.
Publicerad: (2010-01-01)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
av: Califf, R, et al.
Publicerad: (2003)

Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
av: Shen, L, et al.
Publicerad: (2012)

Study of Impaired Glucose Tolerance in Pulmonary Tuberculosis
av: Jain MK, et al.
Publicerad: (2006-01-01)

Impaired glucose tolerance in sleep disorders.
av: Marietta Keckeis, et al.
Publicerad: (2010-03-01)

Evaluation of a self-administered oral glucose tolerance test
av: Bethel, M, et al.
Publicerad: (2013)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
av: Yupu Liu, et al.
Publicerad: (2022-02-01)

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
av: Shen, L, et al.
Publicerad: (2013)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
av: Hermans, M, et al.
Publicerad: (1996)

Diet and other health-related behaviors of individuals with impaired glucose tolerance, cardiovascular disease (CVD) or CVD risk: A global view from the NAVIGATOR study
av: Bales, C, et al.
Publicerad: (2013)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
av: Gerstein, H, et al.
Publicerad: (2006)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
av: Holman, R
Publicerad: (1996)

Impaired glucose tolerance: who and how treats it?
av: M. N. Mamedov
Publicerad: (2005-12-01)

Florid diabetic complications in impaired glucose tolerance
av: Anil P Bhatt, et al.
Publicerad: (2013-01-01)

Impaired glucose tolerance with neurological manifestations in insulinoma
av: Luis Geraldine Villanueva‐Rodríguez, et al.
Publicerad: (2021-09-01)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
av: Yutaka Inoue, et al.
Publicerad: (2022-06-01)

Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach
av: Theodorakis, M, et al.
Publicerad: (2016)

SERUM URIC ACID LEVEL IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE AS COMPARED TO SUBJECTS WITH NORMAL GLUCOSE TOLERANCE
av: Muhammad Zubair, et al.
Publicerad: (2019-10-01)

Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance
av: Wascher Thomas C, et al.
Publicerad: (2006-04-01)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
av: Wamil, M, et al.
Publicerad: (2020)

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance
av: Sae Aoyama-Sasabe, et al.
Publicerad: (2016-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
av: Nihar Ranjan Mohanty, et al.
Publicerad: (2022-06-01)

Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
av: Eugene Han, et al.
Publicerad: (2020-06-01)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
av: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Publicerad: (2012-01-01)

The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
av: Mohanlal, N, et al.
Publicerad: (2002)

Early detection of impaired glucose tolerance in young adults
av: May, Khin Soe, et al.
Publicerad: (2013)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
av: Susanne Andersson, et al.
Publicerad: (2011-01-01)

Subclinical hypothyroidism and impaired glucose tolerance during pregnancy
av: Wen-Ling Lee, et al.
Publicerad: (2023-01-01)

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
av: James W. Russell, et al.
Publicerad: (2008-06-01)